Roche Subsidiary TIB MOLBIOL Launches LightMix Newborn TREC/SMN1/HBB Kit To Screen Newborns For SMA, SCID And Sickle Cell Disease Simultaneously
This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) simultaneously.Catching these
Roche made a new test that checks babies for three serious diseases at once. This shows the company is growing its business in early disease detection and care.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.